Gynecologic Oncology Articles

No OS Benefit With Chemoradiotherapy in High-Risk Endometrial Cancer
Adjuvant chemotherapy given during and after radiotherapy did not improve 5-year overall survival for patients with high-risk endometrial cancer in the phase III PORTEC-3 trial.
EU Panel Recommends Olaparib Tablets for Ovarian Cancer, Regardless of BRCA Status
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of olaparib tablets (Lynparza) as a maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. 
Radiation Role Remains Uncertain in High-Risk Endometrial Cancer
David G. Mutch, MD, discusses questions surrounding the role of radiation therapy for patients with high-risk endometrial cancer.
Concomitant Chemoradiation Remains Standard in Locally Advanced Cervical Cancer
Standard cisplatin-based concomitant chemoradiation induced superior disease-free survival compared with neoadjuvant chemotherapy followed by radical surgery in women with locally advanced squamous cervical cancer.
Immunotherapy Combos on Horizon for Ovarian Cancer
Several phase III studies are exploring immunotherapy combinations with the potential to disrupt the systemic treatment paradigm for patients with ovarian cancer. 
PARP Combinations Offer New Opportunities in Ovarian Cancer
PARP inhibitor combination regimens have the potential to enhance the relatively modest benefit offered by several monotherapy approaches used for the treatment of patients with ovarian cancer.
PARP Combos With Bevacizumab, Immunotherapy in Development for Ovarian Cancer Treatment
Rebecca C. Arend, MD, discussed novel combinations being investigated for the treatment of patients with ovarian cancer.
Expert Highlights PARP Inhibitor Advancements in Ovarian Cancer, Points to Future Combos
David O'Malley, MD, discusses the excitement surrounding PARP inhibitors for patients with ovarian cancer.
Immune Checkpoint Combinations Show Promise in Endometrioid Disease
Many endometrioid cancers express high RNA levels for multiple immune checkpoints, and this may allow physicians to treat these patients with combination immune therapies. 
Immunotherapy Combinations Slated to Pave the Way in Ovarian Cancer Treatment
Kathleen Moore, MD, discusses combination strategies with immunotherapy for patients with ovarian cancer.
Publication Bottom Border
Border Publication
x